Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives

Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3496-3500. doi: 10.1007/s00259-024-06803-w.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers* / metabolism
  • Europe
  • Humans
  • Lewy Body Disease* / diagnostic imaging
  • Neuroimaging* / methods
  • Parkinson Disease* / diagnostic imaging

Substances

  • Biomarkers